BridgeMD
New treatment option for Circadian Dysrhythmia
Official title PICU-related Sleep and Circadian Dysregulation Pilot Study
ClinicalTrials.gov ID: NCT06505447
What this study is testing
- What it's testing
- A single center pilot trial investigating the feasibility of using actigraphy and salivary melatonin levels to measure the sleep and circadian rhythm of critically ill children aged 3 to 6 years old. This study will also measure the feasibility of providing daytime light exposure as well as restricting all provided nutrition to during daytime hours.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 6
You may be able to join if
- Child age 3 to 6 years old on the day of PICU admission
- English-speaking parent at the bedside
- Child expected to remain in the PICU over 24 to 48 hours
You likely can't join if
- Child is in end-of-life care
- The child is receiving neuromuscular blockade for any reason
- Caregiver or parent not at the bedside
The study team makes the final eligibility decision.
Where it's taking place
- Buffalo, New York, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 6 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Buffalo, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.